SCHEMBL31487103

SCHEMBL31487103

Clc1nc(NCc2ccccc2)c2ccc(-c3cncnc3)n2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.43
APP P05067 1/20 0.43
CYP1A2 P05177 5/20 0.41
CYP3A4 P08684 5/20 0.41
CYP2D6 P10635 5/20 0.41
CYP2C19 P33261 5/20 0.41
HSD17B10 Q99714 4/20 0.41
ALOX15 P16050 2/20 0.41
CDK1 P06493 2/20 0.40
ESR1 P03372 1/20 0.39
ALDH1A1 P00352 5/20 0.37
TSHR P16473 3/20 0.37
CLK4 Q9HAZ1 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPK1 P28482 2/20 0.37
TP53 P04637 2/20 0.37
CYP2C9 P11712 1/20 0.37
PLK1 P53350 1/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31487322 0.89 PDE5A (0.48) PDE5AAPPCDK1ESR1ALDH1A1
SCHEMBL30948905 0.80 PDE5A (0.51) PDE5AAPPCDK1ESR1ALDH1A1
SCHEMBL30948921 0.78 PDE5A (0.49) PDE5AAPPCDK1ESR1ALDH1A1
SCHEMBL30948919 0.78 APP (0.49) PDE5AAPPHSD17B10CDK1ESR1
SCHEMBL31487415 0.75 PDE5A (0.46) PDE5AAPPCDK1ESR1ALDH1A1
SCHEMBL31487162 0.74 CDK1 (0.46) PDE5AAPPCDK1ESR1KDM4E
SCHEMBL31487219 0.73 APP (0.44) PDE5AAPPHSD17B10ALOX15CDK1
SCHEMBL31487047 0.73 APP (0.44) PDE5AAPPALOX15CDK1ESR1
SCHEMBL31487285 0.73 MAPT (0.44) PDE5AAPPCDK1ALDH1A1KMT2A
SCHEMBL31487224 0.73 PDE5A (0.49) PDE5AAPPCDK1ESR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025074096-A1 P97 (VCP) ATPASE INHIBITORS Turbine Simulated Cell Technologies Ltd (GB) 2025-04-10 WO disclosed